Blood Systems Inc., United Blood Services; Revocation of U.S. License No. 183-009

摘要

The Food and Drug Administration (FDA) is announcing the revocation of the establishment license (U.S. License No. 183-009) and the product licenses issued to Blood Systems, Inc., United Blood Services, now doing business as Blood Systems, Inc., for the manufacture of Whole Blood, Red Blood Cells, Plasma, Cryoprecipitated antihemophilic factor (AHF), Platelets, and Source Leukocytes. Blood Systems, Inc., United Blood Services has several locations; only the Lubbock, TX, location is affected by this revocation. In a letter to FDA dated June 8, 1994, the firm voluntarily requested revocation of its establishment license and product licenses at the Lubbock, TX, location and thereby waived an opportunity for a hearing.